Ventas Inc (VTR)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $47.02B
Last updated: Nov 17, 2026 at 11:05 AM ET
Ventas Inc (VTR) Financials: Revenue, Profit and Cash Flow
Ventas reported revenue of $5.83B for the fiscal year ended Dec 31, 2025, up 35.0% from the year before. That year, net income was $261.52M with a net margin of 4.5%, operating cash flow was $1.65B and free cash flow was $1.28B. The quarter ended Sep 30, 2026 had revenue of $1.83B and net income of $67.28M.
Revenue and Margins
The operating margin was 14.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $3.44B, a compound annual rate of 6.0%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $5.83B | +35.0% | -5.9% | 14.2% | 4.5% |
| Dec 2024 | $4.32B | +10.1% | 48.5% | 15.8% | 2.0% |
| Dec 2023 | $3.92B | +7.2% | 49.4% | 10.6% | -0.8% |
| Dec 2022 | $3.66B | +8.1% | 50.4% | 13.2% | -1.1% |
| Dec 2021 | $3.39B | +1.9% | 51.3% | 12.4% | 1.7% |
| Dec 2020 | $3.33B | -14.1% | 55.8% | 17.8% | 13.3% |
| Dec 2019 | $3.87B | +3.4% | 53.2% | 22.2% | 11.3% |
| Dec 2018 | $3.75B | +4.8% | 54.8% | 23.0% | 11.1% |
| Dec 2017 | $3.57B | +3.8% | 58.4% | 17.4% | 38.1% |
| Dec 2016 | $3.44B | N/A | 58.1% | 16.2% | 18.9% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 196.0% from the year before. In the quarter ended Sep 2026, net income fell 2.1% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.83B | $4.32B | $3.92B | $3.66B | $3.39B | $3.33B | $3.87B | $3.75B | $3.57B | $3.44B |
| Cost of revenue | $6.18B | $2.83B | $2.56B | $2.28B | $2.09B | $1.94B | $1.81B | $1.69B | $1.49B | $1.44B |
| Gross profit | -$344.22M | $2.10B | $1.94B | $1.85B | $1.74B | $1.86B | $2.06B | $2.05B | $2.09B | $2.00B |
| Operating income | $826.81M | $681.23M | $415.51M | $483.85M | $421.43M | $591.44M | $857.88M | $861.09M | $622.09M | $556.79M |
| Net income | $261.52M | $88.35M | -$30.30M | -$40.93M | $56.56M | $441.19M | $439.30M | $415.98M | $1.36B | $651.49M |
| EBITDA | $1.58B | $1.22B | $1.24B | $1.05B | $532.92M | $1.17B | $1.42B | $1.29B | $1.47B | $1.41B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.83B | $1.73B | $1.66B | $1.72B | $1.49B | $1.42B | $1.36B | $834.66M | $1.09B | $1.20B | $1.20B | $718.36M |
| Gross profit | N/A | N/A | $655.41M | -$2.13B | $619.08M | $594.00M | $572.37M | $546.00M | $521.35M | $519.18M | $510.66M | $494.99M |
| Operating income | N/A | N/A | $191.56M | $204.18M | $221.52M | $203.42M | $197.69M | $195.79M | $182.05M | $141.65M | $161.74M | $23.40M |
| Net income | $67.28M | $72.22M | $59.05M | $72.99M | $68.71M | $71.46M | $48.36M | $58.73M | $21.00M | $21.17M | -$12.54M | -$84.72M |
Balance Sheet
As of Dec 2025, total debt of $13.01B exceeded cash and equivalents by $12.27B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $27.59B | $26.19B | $24.73B | $24.16B | $24.72B | $23.93B | $24.69B | $22.58B | $23.95B | $23.17B |
| Current assets | $1.33B | $1.35B | $868.20M | $964.59M | $755.12M | $1.53B | $942.15M | $632.79M | $1.96B | $1.12B |
| Cash and equivalents | $741.07M | $897.85M | $508.79M | $122.56M | $149.72M | $413.33M | $106.36M | $72.28M | $81.36M | $286.71M |
| Total liabilities | $14.63B | $15.05B | $14.88B | $13.67B | $13.49B | $13.42B | $13.87B | $12.12B | $12.86B | $12.44B |
| Short-term debt | $0 | $6.40M | $14.01M | $428.23M | $336.45M | $193.49M | $848.73M | $856.41M | $538.70M | $146.54M |
| Long-term debt | $13.01B | $13.52B | $13.49B | $12.30B | $12.03B | $11.90B | $12.16B | $10.73B | $11.28B | $11.13B |
| Shareholder equity | $12.53B | $10.77B | $9.49B | $10.15B | $10.85B | $10.18B | $10.45B | $10.22B | $10.87B | $10.46B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $30.63B | $29.66B | $27.69B | $27.59B | $26.93B | $26.47B | $26.03B | $26.19B | $25.35B | $24.53B | $24.67B | $24.73B |
| Total liabilities | $14.27B | $14.44B | $14.11B | $15.01B | $14.15B | $14.55B | $14.17B | $15.36B | $15.19B | $14.55B | $14.93B | $15.18B |
| Cash and equivalents | $202.01M | $198.96M | $183.61M | $741.07M | $188.62M | $614.20M | $182.34M | $897.85M | $1.10B | $557.08M | $632.44M | $508.79M |
| Shareholder equity | $15.81B | $14.65B | $13.12B | $12.53B | $12.36B | $11.53B | $11.47B | $10.77B | $9.76B | $9.62B | $9.40B | $9.49B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 77.6% of operating cash flow. Dividends came to 67.7% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.65B | $1.33B | $1.12B | $1.12B | $1.03B | $1.45B | $1.44B | $1.38B | $1.43B | $1.35B |
| Capital expenditures | $363.86M | $281.61M | $259.42M | $222.13M | $185.28M | $148.23M | $156.72M | $131.86M | $132.56M | $117.46M |
| Free cash flow | $1.28B | $1.05B | $860.46M | $898.03M | $840.84M | $1.30B | $1.28B | $1.25B | $1.30B | $1.24B |
| Dividends paid | $866.38M | $746.79M | $729.75M | $726.61M | $693.65M | $936.09M | $1.17B | $1.13B | $832.96M | $1.03B |
| Investing cash flow | -$2.69B | -$2.38B | -$184.66M | -$859.22M | -$724.14M | $154.29M | -$1.59B | $324.50M | -$937.11M | -$1.21B |
| Financing cash flow | $873.76M | $1.45B | -$543.75M | -$283.93M | -$558.47M | -$1.30B | $160.67M | -$1.76B | -$671.33M | $96.84M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $489.60M | $556.55M | $394.61M | $471.66M | $378.58M | $475.34M | $321.14M | $373.64M | $353.66M | $335.87M | $266.45M | $279.08M |
| Capital expenditures | N/A | N/A | $971.50M | $137.71M | $92.17M | $75.07M | $58.91M | $87.58M | $72.13M | $72.52M | $49.39M | $99.05M |
| Free cash flow | N/A | N/A | -$576.90M | $333.95M | $286.41M | $400.27M | $262.24M | $286.06M | $281.54M | $263.35M | $217.06M | $180.04M |
Frequently Asked Questions About VTR
What is Ventas' annual revenue?
Ventas reported revenue of $5.83B for the fiscal year ended Dec 31, 2025.
How fast is Ventas' revenue growing?
Revenue was up 35.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 16.8%.
Is Ventas profitable?
Yes. Ventas reported net income of $261.52M for the fiscal year ended Dec 31, 2025, with a net margin of 4.5%.
How much free cash flow does VTR generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.65B minus capital expenditures of $363.86M produced free cash flow of $1.28B.
How much debt does Ventas have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $13.01B, short-term debt of $0 and cash and equivalents of $741.07M.
VTR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors